YHLO

2023-03-02

Summary:





On 28th Feb. in Tunisia, YHLO Sales & Service Office opening party was grandly held in Tunis city!

As the import part of YHLO global strategies and global support and service system, more and more local offices of YHLO will be set up in the near future, and provide better and more timely service for our local partners and customers.

Previous: None

Next: Breaking News!

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA POCT ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +